Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators

被引:5
|
作者
Malosh, Chrysa [1 ,2 ,3 ,4 ]
Turlington, Mark [1 ,2 ,3 ,4 ]
Bridges, Thomas M. [1 ,2 ,3 ]
Rook, Jerri M. [1 ,2 ,3 ]
Noetzel, Meredith J. [1 ,2 ,3 ]
Vinson, Paige N. [1 ,2 ,3 ]
Steckler, Thomas [5 ]
Lavreysen, Hilde [5 ]
Mackie, Claire [6 ]
Bartolome-Nebreda, Jose M. [7 ]
Conde-Ceide, Susana [7 ]
Martinez-Viturro, Carlos M. [7 ]
Piedrafita, Maria [7 ]
Sanchez-Casado, M. Rosa [7 ]
Macdonald, Gregor J. [5 ]
Daniels, J. Scott [1 ,2 ,3 ]
Jones, Carrie K. [1 ,2 ,3 ]
Niswender, Colleen M. [1 ,2 ,3 ]
Conn, P. Jeffrey [1 ,2 ,3 ]
Lindsley, Craig W. [1 ,2 ,3 ,4 ]
Stauffer, Shaun R. [1 ,2 ,3 ,4 ]
机构
[1] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Med Ctr, Nashville, TN 37232 USA
[3] Vanderbilt Specialized Chem Ctr Probe Dev MLPCN, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA
[5] Janssen Res & Dev, Neurosci, B-2340 Beerse, Belgium
[6] Janssen Res & Dev, Discovery Sci ADME Tox, Toledo 45007, Spain
[7] Janssen Res & Dev, Neurosci Med Chem, Toledo 45007, Spain
关键词
Metabotropic glutamate receptor 5 (mGlu(5)); Positive allosteric modulator (PAM); NMDA-RECEPTOR; DISCOVERY; SERIES; SAR;
D O I
10.1016/j.bmcl.2015.10.009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report the optimization of a series of metabotropic glutamate receptor 5 (mGlu(5)) positive allosteric modulators (PAMs) from an acyl dihydropyrazolo[1,5-a]pyrimidinone class. Investigation of exocyclic amide transpositions with this unique 5,6-bicyclic core were conducted in attempt to modulate physicochemical properties and identify a suitable backup candidate with a reduced half-life. A potent and selective PAM, 1-(2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidin-4(5H)-yl) ethanone (9a, VU0462807), was identified with superior solubility and efficacy in the acute amphetamine-induced hyperlocomotion (AHL) rat model with a minimum effective dose of 3 mg/kg. Attempts to mitigate oxidative metabolism of the western phenoxy of 9a through extensive modification and profiling are described. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5115 / 5120
页数:6
相关论文
共 50 条
  • [41] Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2
    Liauw, Brandon Wey-Hung
    Foroutan, Arash
    Schamber, Michael R.
    Lu, Weifeng
    Afsari, Hamid Samareh
    Vafabakhsh, Reza
    ELIFE, 2022, 11
  • [42] Design and synthesis of novel metabotropic glutamate receptor allosteric modulators
    Anna Stankiewicz
    Ryszard Bugno
    Piotr Brański
    Andrzej J. Bojarski
    Pharmacological Reports, 2012, 64 : 473 - 474
  • [43] Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators as Novel Tools for in Vivo Investigation
    Keck, Thomas M.
    Zou, Mu-Fa
    Zhang, Peng
    Rutledge, Rebecca P.
    Newman, Amy Hauck
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (07): : 544 - 549
  • [44] Pharmacology, Signaling and Therapeutic Potential of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators
    Kos, Jackson A.
    Langiu, Monica
    Hellyer, Shane D.
    Gregory, Karen J.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024,
  • [45] Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
    Kampen, Stefanie
    Rodriguez, David
    Jorgensen, Morten
    Kruszyk-Kujawa, Monika
    Huang, Xinyan
    Collins, Michael, Jr.
    Boyle, Noel
    Maurel, Damien
    Rudling, Axel
    Lebon, Guillaume
    Carlsson, Jens
    ACS CHEMICAL BIOLOGY, 2022, 17 (10) : 2744 - 2752
  • [46] Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators
    Shah, Falgun
    Stepan, Antonia F.
    O'Mahony, Alison
    Velichko, Sharlene
    Folias, Alexandra E.
    Houle, Christopher
    Shaffer, Christopher L.
    Marcek, John
    Whritenour, Jessica
    Stanton, Robert
    Berg, Ellen L.
    CELL CHEMICAL BIOLOGY, 2017, 24 (07): : 858 - +
  • [47] Imidazo[1,2-a]pyridines: Orally Active Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor
    Trabanco, Andres A.
    Tresadern, Gary
    Macdonald, Gregor J.
    Antonio Vega, Juan
    Isabel de Lucas, Ana
    Matesanz, Encarnacion
    Garcia, Aranzazu
    Lourdes Linares, Maria
    Alonso de Diego, Sergio A.
    Manuel Alonso, Jose
    Oehlrich, Daniel
    Ahnaou, Abdelah
    Drinkenburg, Wilhelmus
    Mackie, Claire
    Ignacio Andres, Jose
    lavreysen, Hilde
    Maria Cid, Jose
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (06) : 2688 - 2701
  • [48] Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5)
    Luz Martin-Martin, Maria
    Manuel Bartolome-Nebreda, Jose
    Conde-Ceide, Susana
    Alonso de Diego, Sergio A.
    Lopez, Silvia
    Martinez-Viturro, Carlos M.
    Han Min Tong
    Lavreysen, Hilde
    Macdonald, Gregor J.
    Steckler, Thomas
    Mackie, Claire
    Bridges, Thomas M.
    Daniels, J. Scott
    Niswender, Colleen M.
    Noetzel, Meredith J.
    Jones, Carrie K.
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Stauffer, Shaun R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (06) : 1310 - 1317
  • [49] Allosteric activation of metabotropic glutamate receptor 5
    Jojart, Balazs
    Orgovan, Zoltan
    Marki, Arpad
    Pandy-Szekeres, Gaspar
    Ferenczy, Gyorgy G.
    Keseru, Gyorgy M.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (09): : 2624 - 2632
  • [50] Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia
    Fell, Matthew J.
    McKinzie, David L.
    Monn, James A.
    Svensson, Kjell A.
    NEUROPHARMACOLOGY, 2012, 62 (03) : 1473 - 1483